We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants

Delisted

NSPRZ was delisted on the 14th of March, 2022.

4 hedge funds and large institutions have $8.85K invested in InspireMD, Inc. Series B Warrants in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 54 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

75% less capital invested

Capital invested by funds: $36K → $8.85K (-$27.1K)

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.17K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$6K +$2.17K +472,612 New
CH
2
CVI Holdings
Delaware
$1K
UBS Group
3
UBS Group
Switzerland
$1K
AFM
4
Anson Funds Management
Texas
$853
SM
5
Sabby Management
Florida
-$1K -1,067,324 Closed

NSPRZ Hedge Fund Activity: Q2 2019 in Review

4 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q2 2019, worth a combined $8.85K — down 75% from $36K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NSPRZ and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.17K. The largest seller was Sabby Management, exiting entirely with an estimated $1K sold.

  • 4 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q2 2019, down from 5 in Q1 2019.
  • Funds reported $8.85K of InspireMD, Inc. Series B Warrants stock for Q2 2019, down 75% quarter-over-quarter.
  • 1 fund opened new InspireMD, Inc. Series B Warrants positions in Q2 2019 and 2 closed out, a net change of -1 holder.
  • The largest InspireMD, Inc. Series B Warrants buyer in Q2 2019 was Susquehanna International Group, an estimated $2.17K added.
  • The largest InspireMD, Inc. Series B Warrants seller in Q2 2019 was Sabby Management, an estimated $1K sold.

Based on aggregated 13F filings for Q2 2019.